Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 731-740 of 9364

Page
per page
  1. Dronedarone
    A3374 Dronedarone
    Target: Cytochrome P450 (CYP450)|sodium channel|adrenergic receptor|potassium channel|calcium channel
    Summary: CYP3A4 and 2D6 inhibitor,moderate
      ≥27.84 mg/mL
  2. DY131
    A3375 DY131
    Summary: ERRγ agonist
      insoluble in H2O; ≥37.1 mg/mL
  3. E-3810
    A3378 E-3810
    Summary: VEGF/FGF dual inhibitor, potent and selective
      Soluble in DMSO
  4. Ebrotidine
    A3380 Ebrotidine
    Summary: H2-receptor antagonist,competitive
      Soluble in DMSO
  5. Edoxaban
    A3381 Edoxaban
    Target: Factor Xa
    Summary: Factor Xa inhibitor
      ≥27.3 mg/mL
  6. Edoxaban tosylate monohydrate
    A3383 Edoxaban tosylate monohydrate
    Summary: Oral factor Xa inhibitor
      ≥36.91 mg/mL
  7. Elacridar
    A3384 Elacridar
    Target: P-glycoprotein (P-gp)
    Summary: BCRP inhibitor
      ≥56.4 mg/mL
  8. Elacridar hydrochloride
    A3385 Elacridar hydrochloride
    Summary: BCRP and P-GP inhibitor
      Soluble in DMSO
  9. Eltrombopag Olamine
    A3387 Eltrombopag Olamine
    Summary: C-mpl agonist
      insoluble in EtOH; insoluble in H2O; ≥14.12 mg/mL
  10. EMD638683
    A3389 EMD638683
     4 Citation
    Target: SGK
    Summary: SGK1 inhibitor
      insoluble in H2O; ≥18.2 mg/mL

Items 731-740 of 9364

Page
per page